Bioscience

ASU researcher says “cruise ship virus” vaccine developed from tobacco

August 18, 2009

By Flinn Foundation

[Source: Yahoo] — Scientists have developed a vaccine for the common viral infection norovirus from a novel source: a tobacco plant.  The new vaccine was “manufactured” in a tobacco plant using a bioengineered plant virus.  This plant biotechnology opens the door to faster, more inexpensive ways to bring vaccines to the public quickly, especially in times when viruses mutate into unpredictable new strains, said Charles Arntzen, who reported on the vaccine at the American Chemical Society annual meeting, in Washingtopn, D.C.

For more information: ‘Cruise Ship Virus’ Vaccine Stems From Tobacco